Effects of ABO incompatibility in Allogeneic Hematopoietic Stem Cell Transplantation.

[1]  N. Dunbar,et al.  Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue , 2019, Journal of clinical apheresis.

[2]  S. Fuji,et al.  Characterization of Late Acute and Chronic Graft-Versus-Host Disease according to the 2014 National Institutes of Health Consensus Criteria in Japanese Patients. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  V. Nobre,et al.  Assessing the impact of ABO incompatibility on major allogeneic hematopoietic stem cell transplant outcomes: a prospective, single-center, cohort study , 2018, Hematology, transfusion and cell therapy.

[4]  P. Topçuoğlu.  Transfusion policy in allogeneic hematopoietic stem cell transplantation. , 2018, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[5]  M. Labopin,et al.  Impact of ABO incompatibility on patients’ outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT , 2017, Haematologica.

[6]  P. Herzberg,et al.  ABO blood group antigen mismatch has an impact on outcome after allogeneic peripheral blood stem cell transplantation , 2016, Clinical transplantation.

[7]  D. McKenna,et al.  Impact of Graft-Recipient ABO Compatibility on Outcomes after Umbilical Cord Blood Transplant for Nonmalignant Disease. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  N. Dunbar,et al.  Introduction to Special Issue: Clinical Applications of Therapeutic Apheresis: An Evidence Based Approach. 7th Edition , 2016 .

[9]  N. Dunbar,et al.  临床实践中治疗性单采术应用指南——基于美国血浆置换学会编写委员会的循证策略：第七版 , 2016 .

[10]  Nina Worel,et al.  ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation , 2015, Transfusion Medicine and Hemotherapy.

[11]  A. Logan,et al.  ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[12]  D. Gómez-Almaguer,et al.  Allogeneic peripheral blood stem cell transplantation using reduced‐intensity conditioning in an outpatient setting in ABO‐incompatible patients: are survival and graft‐versus‐host disease different? , 2014, Transfusion.

[13]  N. Daniele,et al.  The processing of stem cell concentrates from the bone marrow in ABO-incompatible transplants: how and when. , 2014, Blood transfusion = Trasfusione del sangue.

[14]  J. Lundahl,et al.  Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  J. Schwartz,et al.  How do I approach ABO‐incompatible hematopoietic progenitor cell transplantation? (CME) , 2011, Transfusion.

[16]  M. Robin,et al.  Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  D. Benvegnú,et al.  Successful Hematopoietic Stem Cell Transplantation (hsct), Both Autologous and Allogeneic, Requires a Rapid and Durable Engraftment, with Neutrophil (>500/μl) and Platelet (>20,000/ Μl) Reconstitution. Factors Influencing Engraftment after Autolo- Gous or Allogeneic Hsct Were Investigated in 65 Pati , 2022 .

[18]  M. Hirokawa,et al.  Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program , 2008, Haematologica.

[19]  P. Kalhs,et al.  AB0-incompatible allogeneic hematopoietic stem cell transplantation , 2008, Haematologica.

[20]  R. Wolterbeek,et al.  ABO incompatible stem cell transplantation in children does not influence outcome , 2007, Pediatric blood & cancer.

[21]  A. Barrett,et al.  ABO blood group barrier in allogeneic bone marrow transplantation revisited. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[22]  A. Gratwohl,et al.  Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation , 2002, Bone Marrow Transplantation.

[23]  M. Horowitz,et al.  Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[24]  C Anasetti,et al.  Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. , 2001, Blood.

[25]  A. Barrett,et al.  Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. , 2001, Blood.

[26]  S. Rowley.  Hematopoietic stem cell transplantation between red cell incompatible donor–recipient pairs , 2001, Bone Marrow Transplantation.

[27]  P. Höcker,et al.  Regeneration of erythropoiesis after related‐ and unrelated‐donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems , 2000, Transfusion.

[28]  J. Mayer,et al.  Bone marrow processing for transplantation using the COBE spectra cell separator. , 1999, Journal of hematotherapy & stem cell research.

[29]  K. Neftel,et al.  Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. , 1990, Blood.

[30]  F. Frassoni,et al.  ABO COMPATIBILITY AND ACUTE GRAFT‐VERSUS‐HOST DISEASE FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION , 1988, Transplantation.

[31]  E. Thomas,et al.  Comparison of techniques for dealing with major ABO-incompatible marrow transplants. , 1987, Transplantation proceedings.